NasdaqCM - Delayed Quote USD
GlycoMimetics, Inc. (GLYC)
0.1570
-0.0090
(-5.42%)
At close: June 13 at 4:00:01 PM EDT
0.1507
-0.01
(-4.01%)
After hours: June 13 at 7:49:13 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.72M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| INVUS PUBLIC EQUITIES ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.22 - 0.24 per share. | Indirect | 315,262 | Jul 30, 2024 |
| ROCK EDWIN Officer | Purchase at price 0.25 - 0.27 per share. | Direct | 78,824 | Jun 21, 2024 |
| HAHN BRIAN M Chief Financial Officer | Purchase at price 0.25 per share. | Direct | 4,335 | Jun 18, 2024 |
| JUNIUS DANIEL M Director | Stock Award(Grant) at price 3.00 per share. | Direct | 15,627 | Mar 28, 2024 |
| GOLDBERG MARK ALAN Director | Stock Award(Grant) at price 3.00 per share. | Direct | 13,752 | Mar 28, 2024 |
| KING RACHEL K Director | Stock Award(Grant) at price 3.00 per share. | Direct | 10,002 | Mar 28, 2024 |
| ANDREWS PATRICIA S Director | Stock Award(Grant) at price 2.36 per share. | Direct | 12,251 | Dec 29, 2023 |
| GOLDBERG MARK ALAN Director | Stock Award(Grant) at price 2.36 per share. | Direct | 13,752 | Dec 29, 2023 |
| KING RACHEL K Director | Stock Award(Grant) at price 2.36 per share. | Direct | 10,002 | Dec 29, 2023 |
| ANDREWS PATRICIA S Director | Stock Award(Grant) at price 1.50 per share. | Direct | 12,250 | Sep 29, 2023 |
| GOLDBERG MARK ALAN Director | Stock Award(Grant) at price 1.50 per share. | Direct | 13,750 | Sep 29, 2023 |
| KING RACHEL K Director | Stock Award(Grant) at price 1.50 per share. | Direct | 10,000 | Sep 29, 2023 |
| ROCK EDWIN Officer | Purchase at price 1.38 per share. | Direct | 90,256 | Sep 22, 2023 |
Related Tickers
ABP Abpro Corporation
0.2150
-11.85%
ONCO Onconetix, Inc.
4.7300
-24.90%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4121
+14.79%
ERNA Ernexa Therapeutics Inc.
2.2900
-3.38%
EQ Equillium, Inc.
0.3470
-10.22%
VRPX Virpax Pharmaceuticals, Inc.
0.2320
-2.93%
TNFA TNF Pharmaceuticals, Inc.
0.1370
-10.57%
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
ATHA Athira Pharma, Inc.
0.3040
-1.78%
REVB Revelation Biosciences, Inc.
0.7940
-1.03%